# JBT MAREL Corp: Form 10-Q for the period ended Mar 31, 2022

- Company: [JBT MAREL Corp](/companies/jbtm.md) (CIK 1433660)
- Form: 10-Q
- Filed: 2022-04-29
- Accepted by EDGAR: Apr 29, 2022, 15:07 ET
- Period: 2022-03-31
- Accession: 0001433660-22-000014
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1433660/000143366022000014/jbt-20220331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1433660/000143366022000014/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-01-01 to 2022-03-31 | $469.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 3 months, 2022-01-01 to 2022-03-31 | $108.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2022-01-01 to 2022-03-31 | $30.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2022-01-01 to 2022-03-31 | $2.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-01-01 to 2022-03-31 | $25.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-01-01 to 2022-03-31 | $0.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-01-01 to 2022-03-31 | $0.80 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-01-01 to 2022-03-31 | 32,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2022-01-01 to 2022-03-31 | $39.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2022-01-01 to 2022-03-31 | $26.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months, 2022-01-01 to 2022-03-31 | $3.2m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2022-03-31 | $84.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-03-31 | $777.1m | us-gaap:AssetsCurrent |
| Total assets | at 2022-03-31 | $2.21bn | us-gaap:Assets |
| Current liabilities | at 2022-03-31 | $595.9m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2022-03-31 | $669.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-03-31 | $100.0k | us-gaap:DebtCurrent |
| Shareholders' equity | at 2022-03-31 | $783.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 48,583 characters.

### Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q, our Annual Report on Form 10-K and other materials filed or to be filed by us with the Securities and Exchange Commission, as well as information in oral statements or other written statements made or to be made by us, contain statements that are, or may be considered to be, forward-looking statements. All statements that are not historical facts, including statements about our beliefs or expectations, are forward-looking statements. You can identify these forward-looking statements by the use of forward-looking words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” “foresees” or the negative version of those words or other comparable words and phrases. Any forward-looking statements contained in this Form 10-Q are based upon our historical performance and on current plans, estimates and expectations. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved. These forward-looking statements include, among others, statements relating to the expected impact of the COVID-19 pandemic on our business and our results of operations, our plans to mitigate the impact of the pandemic, our strategic plans, our restructuring plans and expected cost savings from those plans, our liquidity and our covenant compliance. The factors that could cause our actual results to differ materially from expectations include but are not limited to the following factors:

- the duration of the COVID-19 pandemic and the effects of the pandemic on our ability to operate our business and facilities, on our customers, on our workforce resulting in higher labor absenteeism, on our supply chains due to extended delivery times and unavailability of required components and freight, on our cost of labor due to higher labor turnover and shortage of skilled labor and on the economy generally;
- fluctuations in our financial results;
- unanticipated delays or acceleration in our sales cycles;
- deterioration of economic conditions;
- disruptions in the political, regulatory, economic and social conditions of the countries in which we conduct business;
- changes to trade regulation, quotas, duties or tariffs;
- risks associated with acquisitions or strategic investments;
- fluctuations in currency exchange rates;
- increases in energy or raw material prices, freight costs, and inflationary pressures;
- changes in food consumption patterns;
- impacts of pandemic illnesses, food borne illnesses and diseases to various agricultural products;
- weather conditions and natural disasters;
- impact of climate change and environmental protection initiatives;
- our ability to comply with the laws and regulations governing our U.S. government contracts;
- acts of terrorism or war, including the recent conflict between Russia and Ukraine;
- termination or loss of major customer contracts and risks associated with fixed-price contracts, particularly during periods of high inflation;
- customer sourcing initiatives;
- competition and innovation in our industries;
- difficulty in implementing our business strategies, including the timing of our previously announced review of strategic alternatives for the AeroTech platform, our ability to identify or develop any strategic alternatives, execute on material aspects of such strategic alternatives, and whether we can achieve the potential benefits of such strategic alternatives.
- our ability to develop and introduce new or enhanced products and services and keep pace with technological developments;
- difficulty in developing, preserving and protecting our intellectual property or defending claims of infringement;
- catastrophic loss at any of our facilities and business continuity of our information systems;
- cyber-security risks such as network intrusion or ransomware schemes;
- loss of key management and other personnel;
- potential liability arising out of the installation or use of our systems;
- our ability to comply with U.S. and international laws governing our operations and industries;
- increases in tax liabilities;
- work stoppages;
- fluctuations in interest rates and returns on pension assets;
- availability of and access to financial and other resources; and
- the factors described under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our most recent Annual Report on Form 10-K and in this Quarterly Report on Form 10-Q.

In addition, many of the risks and uncertainties facing our business are currently amplified by and will continue to be amplified by the COVID-19 pandemic. Given the highly fluid nature of the COVID-19 pandemic, it is not possible to predict all such risks and uncertainties. Refer to the section below titled “Impact of COVID-19 on our Business” in this Form 10-Q for additional information. If one or more of those or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we projected. Consequently, actual events and results may vary significantly from those included in or contemplated or implied by our forward-looking statements. The forward-looking statements included in this Form 10-Q are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement made by us or on our behalf, whether as a result of new information, future developments, subsequent events or changes in circumstances or otherwise.

### Executive Overview

We are a leading global technology solutions provider to high-value segments of the food and beverage industry with focus on proteins, diversified food and health and automated guided vehicle systems. We design, produce, and service sophisticated products and systems for multi-national and regional customers through our FoodTech segment. We also sell critical equipment and services to domestic and international air transportation customers through our AeroTech segment.

In early 2022, we announced our Elevate 2.0 strategy that capitalizes on favorable trends, as well as our leadership position, in the food and beverage processing industry. This strategy is based on a four-pronged approach to deliver continued growth and margin expansion.

- ***Organic Growth***. Our broad application knowledge, engineering expertise, and global sales and service allow us to work alongside our customers to develop critical FoodTech products and solutions across a diverse set of food & beverage end markets. JBT is benefiting from strong commercial and market trends, which create meaningful opportunities for continued new product innovation and R&D in support of our customers’ needs. Additionally, our cross-selling abilities, investment opportunities in developing geographies, and aftermarket capabilities provide meaningful growth opportunities for FoodTech globally.
- ***Digital Transformation.*** We are investing to evolve our iOPS platform into a new digital solution called OmniBlu™, a customer-centric platform that delivers improved access to inventory and service, advanced functionality, and measurable results for customers, while also expanding JBT's recurring revenue from aftermarket parts and services.
- ***Margin Enhancement.*** We see opportunities to improve our operating margins by 200 basis points or more in the medium-term, primarily through supply chain and strategic sourcing initiatives. Key areas of focus include supply base consolidation, make versus buy decisions, value engineering and component standardization, and best cost country sourcing.
- ***Acquisitions.*** We are also continuing our strategic acquisition program focused on companies that add complementary products and technology solutions, which enable us to offer more comprehensive solutions to customers and meet our economic criteria for returns and synergies.

In pursuit of the above strategy, we are considering a full range of strategic alternatives for AeroTech and expect to complete our strategic assessment in the first half of 2023.

We operate under the JBT Business System which provides a level of process rigor across the Company and is designed to standardize and streamline reporting and problem resolution processes for increased visibility, efficiency, effectiveness and productivity in all business units.

Our approach to Environmental, Social and Corporate Governance (ESG) builds on our culture and long tradition of concern for our employees’ health, safety, and well-being; partnering with our customers to find ways to make better use of the earth’s precious resources; and giving back to the communities where we live and work. Our FoodTech equipment and technologies continue to deliver quality performance while striving to minimize food waste, extend food product life, and maximize efficiency in order to create shared value for our food and beverage customers. Our AeroTech equipment business offers a variety of power options, including electrically powered ground support equipment, that help customers meet their environmental objectives. We recognize the responsibility we have to make a positive impact on our shareholders, the environment and our communities in a manner that is consistent with our fiduciary duties. We have engaged in structured education for enhancing inclusive leadership skills in our organization designed to ensure more diversity in our leadership and hiring practices.

We evaluate our operating results considering key performance indicators including segment operating profit, segment operating profit margin, segment EBITDA (adjusted when appropriate) and segment EBITDA margins.

### Business Conditions and Outlook

In terms of top–line growth, we continued to experience a healthy demand for our goods and services in most geographical regions during the first quarter of 2022. Higher demand in FoodTech is driven by customer needs for greater capacity, labor savings, and new product introductions. On the AeroTech side, we continue to experience a gradual recovery, as expected, but do not expect a full recovery for AeroTech to pre-pandemic level until the year 2023, at the earliest. Looking ahead, we anticipate revenue growth to be consistent and solid through 2022 due to continued momentum in overall customer demand for our products and services and a record backlog entering into 2022.

Despite significant growth in our revenues, our operating margins declined in the quarter due to the challenges associated with supply chain disruptions, high inflation, and labor availability affecting both FoodTech and AeroTech. Unlike in the past, where our JBT Business System enabled us to plan and optimize production efficiency, supply chain disruptions and labor shortages meant we often had to stop and start production based on availability. We expect these trends to continue, and potentially be further impacted by the Ukraine conflict throughout 2022, as we anticipate continued disruptions, shortages and price increases - the effect of which will depend in part on our ability to successfully mitigate and offset the impact of these events. Thus far, actions taken by us to mitigate supply chain disruptions and inflation, including productivity improvements, expanding our supplier network, and price increases, have generally been successful in offsetting some, but not all, of the impact of these trends. Additionally, we have continued to enhance our internal operating efficiency with the ongoing benefits of our restructuring program.

As a result of the war in Ukraine, we have made the decision to suspend commercial activities in Russia, Belarus and occupied regions of Ukraine. This consists of ceasing our efforts to seek new business opportunities in these areas, as well as suspending any in-process projects to allow for an assessment of our ability to complete those projects and to receive payments in full compliance with applicable sanction programs, and without risk to our personnel and subcontractors. The direct impact of this action to our consolidated results of operations is and is expected to remain immaterial. Furthermore, we have no direct active operations in any of these countries.

### Impact of COVID-19 on our Business

While we expect the impacts of COVID-19 on our business to moderate, there still remains uncertainty around the pandemic that may continue to result in significant economic disruption, and as a result adversely affecting our business. While we have seen and expect to continue to see positive signs of economic recovery, the following uncertainties still exist and may contribute to additional negative impacts on our overall financial results, particularly if there is a significant resurgence of COVID-19 infections in locations where we or our customers operate:

- our ability to obtain raw material and required components from domestic and international suppliers required to manufacture our products and provide services;
- our ability to efficiently operate our facilities and meet customer obligations due to modified employee work patterns resulting from social distancing guidelines, absence due to illness and cautionary quarantines and/or government ordered closures, or due to labor shortages;
- our ability to secure inbound and outbound logistics to and from our facilities, with additional delays linked to international border crossings and the associated approvals and documentation;
- our ability to access customer locations in order to execute installations, new product deliveries, maintenance and repair services;
- limitations on the ability of our customers to conduct their business, and resulting impacts to our customers' purchasing patterns, from food and travel disruption, social distancing guidelines, absence due to illness or government ordered closures; and
- limitations on the ability of our customers to meet their financial obligations to JBT.

As a result of the global COVID-19 related restrictions and social distancing requirements that have continued since 2020, the food industry continues to experience an elevated level of retail demand. In addition, with these global health restrictions lifting in many parts of the world as a result of decreased infection rates and political pressures, foodservice continues to revitalize as restaurants reopen and travel increases. This increase in demand, however promising, are dependent on the continued trend towards reopening which can be negatively impacted by new variants and a resulting increase in COVID-19 infections and hospitalizations. As there continues to be uncertainty, the pace of recovery from the COVID-19 pandemic remains unpredictable.

As FoodTech customers are present in both the retail and foodservice channels, the shifts in demand have and may continue to create volatility and uncertainty in our customer's purchasing patterns. In the first quarter of 2022, our inbound FoodTech orders increased as we continue to see comparable demand specifically from food processing customers in the quick service restaurant businesses, those servicing the sustained "eat-at-home" trend and ready meals, as well as capital investments continuing to ramp back up for our foodservice and pet food customers. Our customers continue to invest to support these trends, addressing their immediate capacity needs and creating strong interest in FoodTech's broad product offerings. Despite this demand, we expect that continued supply chain challenges as well as labor shortages that have impacted many of our markets will continue to drive delays and inefficiencies in our production process and offset some of these improvements in orders. In addition to the above considerations, although the pandemic continues to have negative impacts on our results of operations in FoodTech, we believe it has accelerated the demand for automation solutions, increased focus on food safety and hygiene requirements and lead to innovation to respond to changes in consumer preferences. Furthermore, recurring revenue for the FoodTech segment has increased 16% year over year. This improvement is driven largely by the demand across the food processing industry noted above, price increases, higher equipment install base due to organic and inorganic growth as well as sustained operations within the food processing companies requiring critical maintenance and parts.

For AeroTech, a large portion of our revenue depends on the passenger airline industry. Passenger air travel continues to increase from 2020 levels with declining infection rates and reopening of travel routes. Activity at US airports continued to increase during the first quarter of 2022 compared to the same period in 2021, driving improving demand for our equipment and services. However, global passenger traffic continues to be well below pre-pandemic levels which directly impacts our mobile equipment business. We are not expecting full recovery for AeroTech to pre-pandemic level until 2023 at the earliest. Although our projections are subject to more uncertainty than in pre-pandemic periods, we expect higher demand and inbound orders for these products for the remaining period of the year 2022. During first quarter of 2022, supply chain disruptions and labor shortages continued to drive shipment delays, operational inefficiencies, and higher material, labor and freight costs which reduced AeroTech's profitability.

Furthermore, while an outbreak of COVID-19 in any of our production manufacturing facilities could lead to a temporary shut-down that may negatively impact our results, there are no significant concentrations of our operations across our manufacturing facilities such that a short-term single plant closure would be expected to have a material impact to our consolidated results.

Although we cannot reasonably estimate the duration and severity, or potential for resurgence, of these COVID-19 related events or the continued impact of the pandemic will have on the global economy or our business, we believe that our positive order trends, improving revenues and strong balance sheet and cash flows has allowed us to emerge from these events well-positioned for long-term growth. For a discussion of the risks and uncertainties associated with the COVID-19 pandemic, see “The COVID-19 pandemic could have a material adverse impact on our business operations, results of operations, cash flows and financial position” in Item 1A. Risk Factors of our most recent Annual Report on Form 10-K.

### Our Strategy to Mitigate Impacts of COVID-19

As we manage through these uncertainties, our focus is on obtaining orders, maintaining disciplined working capital management, identifying ways to mitigate the supply chain disruptions, labor shortages and resulting inefficiencies, and investing in key growth strategies so that we can continue to execute our operating strategies as a critical supplier to the essential food and air transportation industries. As of the date of this filing, all of our factories and warehouses are operational.

We continue to maintain protocols under the guidance of our Crisis Response Team to protect the health and safety of our workers in our facilities, including where appropriate, daily symptoms screening for clearance to work, social distancing requirements in our workplaces, face covering requirements where social distancing is not possible, facilitation of work from home arrangements for our employees who can perform work functions remotely, and global travel restrictions consistent with the Centers for Disease Control and Prevention and local government guidelines. Our Crisis Response Team issues frequent guidance to our managers and employees to reinforce these protocols and policies which are designed to keep our employees safe, maintain our business operations, and allow us to effectively and efficiently manage through positive COVID cases and potential shut downs in our facilities. Furthermore, we are providing enhanced remote support options and extended hours to our customers to support them through the disruption caused by the pandemic.

We will continue to actively monitor the situation and may take further actions that alter our business operations as may be required by federal, state or local authorities or that we determine are in the best interests of our employees and our other stakeholders.

### Non-GAAP Financial Measures

We present non-GAAP financial measures in this quarterly report on Form 10-Q. These non-GAAP financial measures exclude certain amounts that are included in a measure calculated under U.S. GAAP, or include certain amounts that are excluded from a measure calculated under U.S. GAAP. By excluding or including these items, we believe we provide greater transparency into our operating results and trends, and a more meaningful comparison of our ongoing operating results, consistent with how management evaluates performance. Management uses these non-GAAP financial measures in financial and operational evaluation, planning and forecasting. The adjustments generally fall within the following categories: restructuring costs, M&A related costs, pension-related costs, constant currency adjustments and other major items affecting comparability of our ongoing operating results.

The non-GAAP financial measures presented in this report may differ from similarly-titled measures used by other companies. The non-GAAP financial measures are not intended to be used as a substitute for, nor should they be considered in isolation of, financial measures prepared in accordance with U.S. GAAP.

Additional details for each Non-GAAP financial measure follow:

- *Free cash flow*: We define free cash flow as cash provided by operating activities, less capital expenditures, plus proceeds from sale of fixed assets and pension contributions. For free cash flow purposes we consider contributions to pension plans to be more comparable to payment of debt, and therefore exclude these contributions from the calculation of free cash flow.
- *Adjusted net income and Adjusted diluted earnings per share:* We adjust earnings for restructuring expense, M&A related costs, which include integration costs and the amortization of inventory step-up from business combinations, advisory and transaction costs for both potential and completed M&A transactions and strategy (“M&A related costs”), and impacts from remeasurements of deferred taxes.
- *EBITDA and Adjusted EBITDA:* We define EBITDA as earnings before income taxes, interest expense and depreciation and amortization. We define Adjusted EBITDA as EBITDA before restructuring, pension expense other than service cost, and M&A related costs.
- *Segment Adjusted Operating Profit and Segment Adjusted EBITDA:* We report segment operating profit, which is the measure of segment profit or loss required to be disclosed in accordance with GAAP. We adjust segment operating profit for restructuring, and M&A related costs. We calculate segment Adjusted EBITDA by subtracting depreciation and amortization from segment adjusted operating profit.
- *Constant currency measures:* We evaluate our results of operations on both an as reported and a constant currency basis. The constant currency presentation excludes the impact of fluctuations in foreign currency exchange rates. We calculate constant currency percentages by converting our financial results in local currency for a period using the average exchange rate for the prior period to which we are comparing.

The tables included below reconcile each non-GAAP financial measure to the most comparable GAAP financial measure.

The table below provides a reconciliation of cash provided by operating activities to free cash flow:

*(In millions)*

|  | Three Months Ended March 31, 2022 | 2021 |
| --- | ---: | ---: |
| **Cash provided by operating activities** | $39.1 | $85.7 |
| Less: capital expenditures | 26.7 | 8.9 |
| Plus: proceeds from sale of fixed assets | 0.1 | 0.6 |
| Plus: pension contributions | 2.0 | 0.2 |
| Free cash flow (FCF) | $14.5 | $77.6 |

The table below provides a reconciliation of net income as reported to adjusted net income and adjusted diluted earnings per share.

*(In millions, except per share data)*

|  | Three Months Ended March 31, 2022 | 2021 |
| --- | ---: | ---: |
| Net income | $25.6 | $27.0 |
| Non-GAAP adjustments |  |  |
| Restructuring related costs |  |  |
| Restructuring expense | 0.5 | 1.0 |
| Inventory impairment due to restructuring | 0.2 | — |
| M&A related cost | 2.6 | 1.4 |
| Impact on tax provision from Non-GAAP adjustments(1) | (0.9) | (0.6) |
| Adjusted net income | $28.0 | 28.8 |
| Net income | 25.6 | 27.0 |
| Total shares and dilutive securities | 32.1 | 32.1 |
| Diluted earnings per share from net income | 0.80 | 0.84 |
| Adjusted net income | 28.0 | 28.8 |
| Total shares and dilutive securities | 32.1 | 32.1 |
| Adjusted diluted earnings per share from net income | 0.87 | 0.90 |

(1) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for the quarters ended March 31, 2022 and 2021, respectively.

The tables below provide a reconciliation of net income to EBITDA and Adjusted EBITDA:

*(In millions)*

|  | Three Months Ended March 31, 2022 | 2021 |
| --- | ---: | ---: |
| Net income | 25.6 | 27.0 |
| Income tax provision | 2.9 | 8.7 |
| Interest expense, net | 2.1 | 2.1 |
| Depreciation and amortization | 19.9 | 18.3 |
| EBITDA | 50.5 | 56.1 |
| Restructuring related costs |  |  |
| Restructuring expense | 0.5 | 1.0 |
| Inventory impairment due to restructuring | 0.2 | — |
| M&A related cost | 2.6 | 1.4 |
| Adjusted EBITDA | $53.8 | $58.5 |

The tables below provide a reconciliation of segment operating profit to segment adjusted operating profit and segment Adjusted EBITDA:

*(In millions)*

|  | Three Months Ended March 31, 2022 JBT FoodTech | JBT AeroTech | Corporate (Unallocated) | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Operating profit | $39.9 | $6.8 | $(16.1) | $30.6 |
| Restructuring related costs |  |  |  |  |
| Restructuring expense | — | — | 0.5 | 0.5 |
| Inventory impairment due to restructuring | 0.2 | — | — | 0.2 |
| M&A related cost | 0.3 | — | 2.3 | 2.6 |
| Adjusted operating profit | 40.4 | 6.8 | (13.3) | 33.9 |
| Depreciation and amortization | 17.7 | 1.2 | 1.0 | 19.9 |
| Adjusted EBITDA | $58.1 | $8.0 | $(12.3) | $53.8 |
| Revenue | $356.3 | $112.9 | $— | $469.2 |
| Operating profit % | 11.2% | 6.0% |  | 6.5% |
| Adjusted operating profit % | 11.3% | 6.0% |  | 7.2% |
| Adjusted EBITDA % | 16.3% | 7.1% |  | 11.5% |

27

*(In millions)*

|  | Three Months Ended March 31, 2021 JBT FoodTech | JBT AeroTech | Corporate (Unallocated) | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Operating profit | $41.5 | $9.9 | $(13.6) | $37.8 |
| Restructuring expense | — | — | 1.0 | 1.0 |
| M&A related cost | 0.5 | — | 0.9 | 1.4 |
| Adjusted operating profit | 42.0 | 9.9 | (11.7) | 40.2 |
| Depreciation and amortization | 16.3 | 1.4 | 0.6 | 18.3 |
| Adjusted EBITDA | $58.3 | $11.3 | $(11.1) | $58.5 |
| Revenue | $311.8 | $106.0 | $— | $417.8 |
| Operating profit % | 13.3% | 9.3% |  | 9.0% |
| Adjusted operating profit % | 13.5% | 9.3% |  | 9.6% |
| Adjusted EBITDA % | 18.7% | 10.7% |  | 14.0% |

28

### CONSOLIDATED RESULTS OF OPERATIONS

### THREE MONTHS ENDED MARCH 31, 2022 AND 2021

*(In millions, except %)*

|  | Three Months Ended March 31, 2022 | 2021 | Favorable/(Unfavorable) Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Total revenue | $469.2 | $417.8 | $51.4 | 12.3% |
| Cost of sales | 329.7 | 284.6 | (45.1) | (15.8)% |
| **Gross profit** | 139.5 | 133.2 | 6.3 | 4.7% |
| **Gross profit %** | 29.7% | 31.9% | -220 bps |  |
| Selling, general and administrative expense | 108.4 | 94.4 | (14.0) | (14.8)% |
| Restructuring expense | 0.5 | 1.0 | 0.5 | 50.0% |
| **Operating income** | 30.6 | 37.8 | (7.2) | (19.0)% |
| **Operating income %** | 6.5% | 9.0% | -250 bps |  |
| Interest expense, net | 2.1 | 2.1 | — | —% |
| **Net income before income taxes** | 28.5 | 35.7 | (7.2) | (20.2)% |
| Income tax provision | 2.9 | 8.7 | 5.8 | 66.7% |
| **Net income** | $25.6 | $27.0 | $(1.4) | (5.2)% |

Total revenue for the three months ended March 31, 2022 increased $51.4 million compared to the same period in 2021. This was a 12% increase primarily driven by organic growth of 12%, and a 3% gain from acquisitions which was offset by a 3% unfavorable foreign currency translation. Growth from organic revenue was the result of increases in both equipment and recurring revenues.

Operating income margin was 6.5% for the three months ended March 31, 2022 compared to 9.0% in the same period in 2021, a decrease of 250 bps, as a result of the following drivers:

- Gross profit margin decreased 220 bps to 29.7% compared to 31.9% in the same period last year. This decrease was the result of the ongoing supply chain disruptions and resulting inefficiencies driving increases in material, logistics and labor costs.
- Selling, general and administrative expense increased $14.0 million from prior year, and as a percent of revenue increased 50 bps to 23.1% compared to 22.6% in the same period last year. This was due to an increase in M&A related costs, costs related to the implementation of our new digital solution, and the return of variable costs that were reduced in prior years as a result of the impact of COVID-19, partially offset by leveraging of fixed costs as volumes increased year-over-year.
- Currency translation decreased operating income by $0.8 million.

Interest expense, net is comparable to the same period in 2021 as decreases driven primarily by lower interest rates were offset by higher average debt levels.

As of the first quarter of 2022, our estimated annual effective tax rate, which excludes discrete tax impacts, was 21.6%. Our actual effective tax rate for the three months ended March 31, 2022 of 10.2% was favorably impacted by discrete items totaling $3.2 million, primarily driven by a $1.5 million tax benefit from the UK patent box regime and a $1.4 million tax benefit from the resolution of Brazilian tax litigation.

As of the first quarter of 2021, our estimated annual effective tax rate, which excluded discrete tax impacts, and our actual effective tax rate for the three months ended March 31, 2021 were both 24.4%.

The reduction in our estimated annual effective operating rate is primarily driven by benefits related to the UK patent box regime, non-taxable Brazilian state incentives, and a reduction in non-deductible executive compensation. In addition, beginning in 2022, the Tax Cuts and Jobs Act of 2017 eliminated the option to deduct research and development expenditures immediately in the year incurred, and requires taxpayers to amortize such expenditures in the U.S. over five years. While the capitalization requirement has a material negative impact on cash flows, there are offsetting benefits from the enactment of this provision that we have included in our estimated annual effective tax rate, including an increase to our R&D tax credit. Congress has proposed tax legislation to delay the effective date of this change, but it is uncertain whether the proposed delay will ultimately be enacted into law. If it is delayed, these effective tax rate benefits will not be realized in the current year.

### OPERATING RESULTS OF BUSINESS SEGMENTS

### THREE MONTHS ENDED MARCH 31, 2022 AND 2021

*(In millions, except %)*

| Revenue | Three Months Ended March 31, 2022 | 2021 | Favorable/(Unfavorable) Change% |  |
| --- | ---: | ---: | ---: | ---: |
| JBT FoodTech | $356.3 | $311.8 | $44.5 | 14.3% |
| JBT AeroTech | 112.9 | 106.0 | 6.9 | 6.5% |
| Total revenue | $469.2 | $417.8 | $51.4 | 12.3% |
| **Operating income before income taxes** |  |  |  |  |
| Segment operating profit(1)(2): |  |  |  |  |
| JBT FoodTech | $39.9 | $41.5 | $(1.6) | (3.9)% |
| JBT FoodTech segment operating profit % | 11.2% | 13.3% | -210 bps |  |
| JBT AeroTech | 6.8 | 9.9 | (3.1) | (31.3)% |
| JBT AeroTech segment operating profit % | 6.0% | 9.3% | -330 bps |  |
| Total segment operating profit | 46.7 | 51.4 | (4.7) | (9.1)% |
| Total segment operating profit % | 10.0% | 12.3% | -230 bps |  |
| Corporate items: |  |  |  |  |
| Corporate expense | 15.6 | 12.6 | (3.0) | (23.8)% |
| Restructuring expense | 0.5 | 1.0 | 0.5 | 50.0% |
| Operating income | $30.6 | $37.8 | $(7.2) | (19.0)% |
| Operating income % | 6.5% | 9.0% | -250 bps |  |
| Inbound orders: |  |  |  |  |
| JBT FoodTech | $411.8 | $385.7 |  |  |
| JBT AeroTech | 153.7 | 100.4 |  |  |
| Total inbound orders | $565.5 | $486.1 |  |  |

(1) Refer to Note 14. Business Segment Information of the Notes to Condensed Consolidated Financial Statements.

(2) Segment operating profit is defined as total segment revenue less segment operating expense. Corporate expense, restructuring expense, interest income and expense and income taxes are not allocated to the segments. Corporate expense generally includes corporate staff-related expense, stock-based compensation, LIFO adjustments, certain foreign currency-related gains and losses, and the impact of unusual or strategic events not representative of segment operations.

### JBT FoodTech

FoodTech revenue increased by $44.5 million or 14.3% for the first quarter ended March 31, 2022 compared to the same period in 2021. Organic revenue grew $41.2 million in the period and revenue from acquisitions grew $13.9 million. Foreign currency translation was unfavorable by $10.6 million in the quarter. Non-recurring revenue represented 61% of the organic revenue growth on a constant currency basis, with $25 million of additional revenue in the year compared to 2021. Recurring revenue drove the remaining increase in organic revenue of $16.2 million.

FoodTech operating profit decreased $1.6 million, or 3.9%, for the quarter ended March 31, 2022 compared to the same period in 2021. Gross profit margins declined ~200 bps year over year contributing to a lower operating profit margin of 11.2% in 2022 compared to 13.3% in the prior year. Operating and gross profit margins declined in 2022 compared to 2021 despite revenue growth due largely to continued supply chain disruptions and pressures resulting in inefficiencies that drove ongoing increases in material, freight, and labor costs. Selling, general and administrative expense increased $9.9 million from prior year, but as a percent of revenue remained flat at 22.4% in both the current and prior year. Currency translation had an immaterial impact.

### JBT AeroTech

JBT AeroTech's revenue increased $6.9 million or 7% in the first quarter of 2022 compared to the same period in 2021. This increase is comprised of a $6.0 million increase from our mobile equipment business and a $5.8 million increase from our service business, partially offset by a decline of $5.2 million in our fixed equipment business. Foreign currency translation was unfavorable by $0.2 million. The increase in our mobile equipment business was driven by higher equipment sales to cargo customers and higher aftermarket sales primarily as a result of the continued industry recovery from COVID-19. The increase in service revenue was a result of an increase in service hours on our maintenance contracts as activity at US airports began to increase as a result of the elimination of customer-imposed service hour reductions relating to COVID-19 compared to the prior year. The decline in our fixed equipment business was primarily due to supply chain issues and labor shortages.

JBT AeroTech’s operating profit declined $3.1 million or 31.3% in the first quarter of 2022 compared to 2021. Gross profit margins decreased 290 bps driven by higher material, labor and freight costs. These increased costs contributed to a lower operating profit margin of 6.0% compared to 9.3% in the prior year, reflecting a decline of 330 bps. Selling, general and administrative expenses in 2022 were $1.2 million above 2021 which is an increase of 10%. The increase in 2022 was mostly due to inflation and increase in variable costs that were reduced in the prior year as a result of the impact of COVID-19. Currency translation had an immaterial impact.

### Corporate Expense

Corporate expense increased $3.0 million during the three months ended March 31, 2022, compared to the same period in 2021. The increase was driven primarily by higher M&A related costs and costs related to implementation of our new digital solution. Corporate expense increased as a percentage of sales from 3.0% in the prior year to 3.3% for the three months ended March 31, 2022.

### Restructuring

In the third quarter of 2020, the Company implemented a restructuring plan ("2020 restructuring plan") for manufacturing capacity rationalization affecting both the JBT FoodTech and JBT AeroTech segments. The total estimated cost in connection

with this plan is approximately $11 million for FoodTech and approximately $6 million for AeroTech to be completed by second quarter of 2022. We recognized restructuring charges of $18.0 million, net of a cumulative release of the related liability of $1.6 million, through March 31, 2022.

The following table details the cumulative amount of annualized savings and incremental savings for the 2020 restructuring plan:

*(In millions)*

|  | Cumulative Amount As of December 31, 2021 | Incremental Amount During the quarter ended March 31, 2022 | Cumulative Amount As of March 31, 2022 |
| --- | ---: | ---: | ---: |
| Cost of sales | $5.0 | $1.0 | $6.0 |
| Selling, general and administrative | 1.9 | 0.5 | 2.4 |
| Total restructuring savings | $6.9 | $1.5 | $8.4 |

For the 2020 restructuring plan, incremental cost savings we expect to realize during the remaining of the current year are as follows:

*(In millions)*

|  | Remainder of 2022 (est.) |
| --- | ---: |
| Cost of sales | $0.4 |
| Selling, general and administrative | 0.3 |
| **Total expected incremental cost savings** | $0.7 |

For additional financial information about restructuring, refer to Note 15. Restructuring of the Notes to Condensed Consolidated Financial Statements.

### Liquidity and Capital Resources

### Overview of Sources and Uses of Cash

Our primary sources of liquidity are cash flows provided by operating activities from our U.S. and foreign operations, borrowings from our revolving credit facility, and proceeds from the issuance of the convertible notes on May 28, 2021.

As of March 31, 2022, we had $84.2 million of cash and cash equivalents, $35.5 million of which was held by our foreign subsidiaries. Although certain funds are considered permanently invested in our foreign subsidiaries, we are not presently aware of any restriction on the repatriation of these funds. We maintain significant operations outside of the U.S., and many of our uses of cash for working capital, capital expenditures and business acquisitions arise in these foreign jurisdictions. If these funds were needed to fund our operations or satisfy obligations in the U.S., they could be repatriated and their repatriation into the U.S. could cause us to incur additional U.S. income tax and foreign withholding taxes. The foreign withholding taxes on these repatriations to the U.S. would potentially be partially offset by U.S. foreign tax credits.

As noted above, certain funds held outside of the U.S. are considered permanently invested in our non-U.S. subsidiaries. At times, these foreign subsidiaries have cash balances that exceed their immediate working capital or other cash needs. In these circumstances, the foreign subsidiaries may loan funds to the U.S. parent company on a temporary basis; the U.S. parent company has in the past and may in the future use the proceeds of these temporary intercompany loans to reduce outstanding borrowings under our committed credit facilities. By using available non-U.S. cash to repay our debt on a short-term basis, we can optimize our leverage ratio, which has the effect of lowering our interest costs.

Under Internal Revenue Service (IRS) guidance, no incremental tax liability is incurred on the proceeds of these loans as long as each individual loan has a term of 30 days or less and all such loans from each subsidiary are outstanding for a total of less than 60 days during the year. During 2022, any such loan was outstanding for less than 30 days, and all such loans were outstanding for less than 60 days in the aggregate. We used the proceeds of these intercompany loans to reduce outstanding borrowings under our revolving credit facility. We may choose to access such funds again in the future to the extent they are available and can be transferred without significant cost, and use them on a temporary basis to repay outstanding borrowings or for other corporate purposes, but intend to do so only as allowed under this IRS guidance. The amount outstanding subject to IRS guidance at March 31, 2022 was approximately $29.5 million.

Beginning in 2022, the Tax Cuts and Jobs Act of 2017 eliminated the option to deduct research and development expenditures immediately in the year incurred and requires taxpayers to amortize such expenditures in the U.S. over five years. Congress has proposed tax legislation to delay the effective date of this change, but it is uncertain whether the proposed delay will ultimately be enacted into law. If the current effective date remains in place, the Company's initial assessment is that we will experience a material decrease in cash from operations in 2022 and the impact will continue over the five-year amortization period, but the impact will decrease each year.

For the three months ended March 31, 2022, we had total operating cash flow of $39.1 million and $14.5 million in free cash flow. For full year 2022, we expect to generate positive cash flows. Our liquidity as of March 31, 2022, or cash plus borrowing ability under our revolving credit facilities, was $686.8 million. The increase in our liquidity year over year was in part due to structural changes in the leverage calculation of our credit facility, modified in the fourth quarter of 2021, that has allowed us increased access to the capacity under our secured credit facility. Furthermore, our liquidity improved resulting from lower borrowing required from our secured credit facility as of March 31, 2022, due to our funding requirements met by the issuance of unsecured convertible notes in May 2021.

The cash flows generated by our operations and borrowings are expected to be sufficient to satisfy our principal cash requirements both in the short term and long term, which include our working capital needs, new product development, restructuring expenses, capital expenditures, income taxes, debt repayments, dividends, share repurchases, periodic pension contributions, payments under the CARES Act for payroll tax deferral, and other financing arrangements.

Based on our current capital allocation objectives, during 2022 we anticipate capital expenditures to be between $90 million and $95 million, which includes about $45 million of capitalized investment in our digital strategy, compared to $54.1 million in the prior year. Our level of capital expenditures varies from time to time as a result of actual and anticipated business conditions. We believe JBT's strong balance sheet, operating cash flows, and access to capital, as of March 31, 2022, positions us to successfully navigate through the current challenging economic conditions as we continue to invest in growth strategies including our acquisition program and new product development.

### Cash Flows

Cash flows for the three months ended March 31, 2022 and 2021 were as follows:

*(In millions)*

|  | Three Months Ended March 31, 2022 | 2021 |
| --- | ---: | ---: |
| Cash provided by operating activities | $39.1 | $85.7 |
| Cash required by investing activities | (27.0) | (24.2) |
| Cash required by financing activities | (7.6) | (50.0) |
| Effect of foreign exchange rate changes on cash and cash equivalents | 0.9 | (1.5) |
| **Increase in cash and cash equivalents** | $5.4 | $10.0 |

Cash provided by operating activities during the three months ended March 31, 2022 was $39.1 million, representing a $46.6 million decrease compared to the same period in 2021. This decrease was driven primarily by higher investment in inventory, lower customer collections for trade receivable, and higher pension contributions partially offset by lower payments for accounts payable and higher customer collection of advance payments.

Cash required by investing activities during the three months ended March 31, 2022 was $27.0 million, an increase of $2.8 million compared to the same period in 2021, primarily due to a higher spending on capital expenditures partially offset by a lower spending on acquisitions year over year.

Cash required by financing activities of $(7.6) million during the three months ended March 31, 2022, a decrease of $42.4 million compared to same period in 2021. This decrease was primarily due a decrease in paying down of borrowings under our revolving credit facility year over year.

### Financing Arrangements

As of March 31, 2022 we had $277.8 million drawn on and $1,015.8 million of availability under the revolving credit facility. Our ability to use this revolving credit facility is limited by the leverage ratio covenant described below.

Our credit agreement includes restrictive covenants that, if not met, could lead to a renegotiation of our credit lines, a requirement to repay our borrowings and/or a significant increase in our cost of financing. Restrictive covenants include a minimum interest coverage ratio, a maximum leverage ratio, as well as certain events of default. As of March 31, 2022, we were in compliance with all covenants in our credit agreement. We expect to remain in compliance with all covenants in the foreseeable future. However, there can be no assurance that continued or increased volatility in global economic conditions will not impair our ability to meet our covenants, or that we will continue to be able to access the capital and credit markets on terms acceptable to us or at all.

On May 28, 2021, we closed a private offering of $402.5 million aggregate principal amount of the Company's 0.25% Convertible Senior Notes due 2026 to qualified institutional buyers, resulting in net proceeds to us of approximately $392.2 million after deducting initial purchasers’ discounts. The convertible notes will mature on May 15, 2026 unless earlier converted, redeemed or repurchased. Concurrently with the issuance of the convertible notes, we entered into the convertible note hedge transactions that reduce potential dilution upon conversion of the Notes and into the warrant transactions to raise additional capital to partially offset the costs of entering into the convertible note hedge transactions.

For additional information about our convertible secured notes, convertible note hedge and warrant transactions, refer to Note 6. Debt of the Notes to Condensed Consolidated Financial Statements.

As of March 31, 2022, we have entered into four interest rate swaps executed in March 2020 with a combined notional amount of $200 million expiring in April 2025, and one interest rate swap executed in May 2020 with a notional amount of $50 million expiring in May 2025. We have designated these swaps as cash flow hedges and all changes in fair value of the swaps are recognized in Accumulated other comprehensive income (loss). As a result, as of March 31, 2022 a portion of our variable rate

debt was effectively fixed rate debt subject to an average fixed rate of 0.81%, while approximately $27.8 million, or 10%,

remained subject to floating, or market, rates. To the extent interest rates increase in future periods, our earnings could be

negatively impacted by higher interest expense.

### CRITICAL ACCOUNTING ESTIMATES

There were no material changes in our judgments and assumptions associated with the development of our critical accounting estimates during the period ended March 31, 2022. Refer to our Annual Report on Form 10-K for the year ended December 31, 2021 for a discussion of our critical accounting estimates.

## Market risk

As filed, 162 characters.

There have been no material changes in reported market risks from the information reported in our Annual Report on Form 10-K for the year ended December 31, 2021.

## Controls and procedures

As filed, 1,538 characters.

Under the direction of our principal executive officer and principal financial officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of March 31, 2022. We have concluded that, as of March 31, 2022, our disclosure controls and procedures were:

i) effective in ensuring that information required to be disclosed is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and

ii) effective in ensuring that information required to be disclosed is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

In the ordinary course of business, we review our system of internal control over financial reporting and make changes to our systems and processes to improve such controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, automating manual processes and updating existing systems.

There were no changes in controls identified in the evaluation for the quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act.

## Risk factors

As filed, 908 characters.

In addition to the other information set forth in this report, you should carefully consider the risk factor below and factors discussed in Item 1A. "Risk Factors" in JBT's Annual Report on Form 10-K for the year ended December 31, 2021.

### BUSINESS STRATEGY RISKS

***We face risks associated with our evaluation of strategic alternatives for our AeroTech platform.***

As previously disclosed, we are evaluating strategic alternatives for our AeroTech platform. The goal of this evaluation is to identify the most value-creating opportunity for our shareholders. Potential risks include the diversion of management’s attention from other business concerns, the potential loss of key employees and customers, potential impairment charges or losses if a business were to be divested at a loss, and restructuring and other disposal charges. Any or all these risks could impact the Company’s financial results.

Filed Apr 29, 2022.
Source: SEC EDGAR, the filing index for accession 0001433660-22-000014. Last ingested by Listed: Nov 3, 2026, 21:30 ET. No prices; not investment advice.
